Biomarkers of PD progression Is CSF the answer?

被引：2

作者：

Aarsland, Dag ^{[1
,2
]}

Ravina, Bernard ^{[3
]}

机构：

[1] Univ Oslo, Stavanger Univ Hosp, Div Psychiat, N-4005 Stavanger, Norway

[2] Univ Oslo, Akershus Univ Hosp, N-4005 Stavanger, Norway

[3] Univ Rochester, Sch Med & Dent, Dept Neurol, Rochester, NY 14642 USA

来源：

NEUROLOGY | 2010年 / 75卷 / 12期

关键词：

PARKINSONS-DISEASE; ALPHA-SYNUCLEIN; LEWY BODIES; DEMENTIA; ALZHEIMERS;

D O I：

10.1212/WNL.0b013e3181f6f272

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：1036 / 1037

页数：2

共 10 条

[1] ALVES G, 2010, J NEUROL NEUROSURG P
[2] α-synuclein antibodies recognize a protein present at lower levels in the CSF of patients with dementia with Lewy bodies
Ballard, Clive
Jones, Emma L.
Londos, Elisabet
Minthon, Lennart
Francis, Paul
Aarsland, Dag
[J]. INTERNATIONAL PSYCHOGERIATRICS, 2010, 22 (02) : 321 - 327
[3] CSF amyloid-β-peptides in Alzheimer's disease, dementia with Lewy bodies and Parkinson's disease dementia
Bibl, M
Mollenhauer, B
Esselmann, H
Lewczuk, P
Klafki, HW
Sparbier, K
Smirnov, A
Cepek, L
Trenkwalder, C
Rüther, E
Kornhuber, J
Otto, M
Wiltfang, J
[J]. BRAIN, 2006, 129 : 1177 - 1187
[4] In vivo amyloid imaging in autopsy-confirmed Parkinson disease with dementia
Burack, M. A.
Hartlein, J.
Flores, H. P.
Taylor-Reinwald, L.
Perlmutter, J. S.
Cairns, N. J.
[J]. NEUROLOGY, 2010, 74 (01) : 77 - 84
[5] Clinical diagnostic criteria for dementia associated with Parkinson's disease
Emre, Murat
Aarsland, Dag
Brown, Richard
Bum, David J.
Duyckaerts, Charles
Mizuno, Yoshikino
Broe, Gerald Anthony
Cummings, Jeffrey
Dickson, Dennis W.
Gauthier, Serge
Goldman, Jennifer
Goetz, Christopher
Korczyn, Amos
Lees, Andrew
Levy, Richard
Litvan, Irene
McKeith, Ian
Olanow, Warren
Poewe, Werner
Quinn, Niall
Sampaio, Christina
Tolosa, Eduardo
Dubois, Bruno
[J]. MOVEMENT DISORDERS, 2007, 22 (12) : 1689 - 1707
[6] Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade
Jack, Clifford R., Jr.
Knopman, David S.
Jagust, William J.
Shaw, Leslie M.
Aisen, Paul S.
Weiner, Michael W.
Petersen, Ronald C.
Trojanowski, John Q.
[J]. LANCET NEUROLOGY, 2010, 9 (01) : 119 - 128
[7] CSF Biomarkers and Incipient Alzheimer Disease in Patients With Mild Cognitive Impairment
Mattsson, Niklas
Zetterberg, Henrik
Hansson, Oskar
Andreasen, Niels
Parnetti, Lucilla
Jonsson, Michael
Herukka, Sanna-Kaisa
van der Flier, Wiesje M.
Blankenstein, Marinus A.
Ewers, Michael
Rich, Kenneth
Kaiser, Elmar
Verbeek, Marcel
Tsolaki, Magda
Mulugeta, Ezra
Rosen, Erik
Aarsland, Dag
Visser, Pieter Jelle
Schroeder, Johannes
Marcusson, Jan
de Leon, Mony
Hampel, Harald
Scheltens, Philip
Pirttilae, Tuula
Wallin, Anders
Jonhagen, Maria Eriksdotter
Minthon, Lennart
Winblad, Bengt
Blennow, Kaj
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2009, 302 (04): : 385 - 393
[8] Direct quantification of CSF α-synuclein by ELISA and first cross-sectional study in patients with neurodegeneration
Mollenhauer, Brit
Cullen, Valerie
Kahn, Ilana
Krastins, Bryan
Outeiro, Tiago F.
Pepivani, Imelda
Ng, Juliana
Schulz-Schaeffer, Walter
Kretzschmar, Hans A.
McLean, Pamela J.
Trenkwalder, Claudia
Sarracino, David A.
VonSattel, Jean-Paul
Locascio, Joseph J.
El-Agnaf, Omar M. A.
Schlossmacher, Michael G.
[J]. EXPERIMENTAL NEUROLOGY, 2008, 213 (02) : 315 - 325
[9] CSF amyloid β 1-42 predicts cognitive decline in Parkinson disease
Siderowf, A.
Xie, S. X.
Hurtig, H.
Weintraub, D.
Duda, J.
Chen-Plotkin, A.
Shaw, L. M.
Van Deerlin, V.
Trojanowski, J. Q.
Clark, C.
[J]. NEUROLOGY, 2010, 75 (12) : 1055 - 1061
[10] Mechanisms of Hybrid Oligomer Formation in the Pathogenesis of Combined Alzheimer's and Parkinson's Diseases
Tsigelny, Igor F.
Crews, Leslie
Desplats, Paula
Shaked, Gideon M.
Sharikov, Yuriy
Mizuno, Hideya
Spencer, Brian
Rockenstein, Edward
Trejo, Margarita
Platoshyn, Oleksandr
Yuan, Jason X. -J.
Masliah, Eliezer
[J]. PLOS ONE, 2008, 3 (09):

← 1 →